SMARCA2 and nasopharyngeal carcinoma: In the future, the expression pattern of SMARCA2 in NPC patients and its relationship with the effect of radiotherapy can be analyzed by clinical samples to determine its potential as a therapeutic target for sensitization to radiotherapy.